FAKTOR OPTIONSSCHEIN - MEDTRONIC Stock

Certificat

DE000UL54ZE6

Market Closed - Deutsche Boerse AG 01:38:41 2024-06-28 pm EDT
2.4 EUR +2.56% Intraday chart for FAKTOR OPTIONSSCHEIN - MEDTRONIC
Current month-8.75%
1 month-14.89%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-28 2.4 +2.56%
24-06-27 2.34 -4.49%
24-06-26 2.45 -1.21%
24-06-25 2.48 -4.25%
24-06-24 2.59 -1.15%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 01:38 pm EDT

More quotes

Static data

Product typeWarrant Esotici e Strutturati
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer UBS
WKN UL54ZE
ISINDE000UL54ZE6
Date issued 2023-07-14
Strike 59.13 $
Maturity Unlimited
Parity 7.68 : 1
Emission price 5.05
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.7
Lowest since issue 1.8
Spread 0.05
Spread %2.08%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
78.71 USD
Average target price
94.02 USD
Spread / Average Target
+19.46%
Consensus